These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31574970)

  • 1. Cost-Effectiveness Study of One-Stage Treatment of Chronic Osteomyelitis with Bioactive Glass S53P4.
    Geurts J; van Vugt T; Thijssen E; Arts JJ
    Materials (Basel); 2019 Sep; 12(19):. PubMed ID: 31574970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.
    Cunha MT; Murça MA; Nigro S; Klautau GB; Salles MJC
    BMC Infect Dis; 2018 Apr; 18(1):157. PubMed ID: 29614973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study.
    Van Vugt TAG; Heidotting J; Arts JJ; Ploegmakers JJW; Jutte PC; Geurts JAP
    J Bone Jt Infect; 2021; 6(9):413-421. PubMed ID: 34804776
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioactive glass S53P4 to fill-up large cavitary bone defect after acute and chronic osteomyelitis treated with antibiotic-loaded cement beads: A prospective case series with a minimum 2-year follow-up.
    Kojima KE; de Andrade E Silva FB; Leonhardt MC; de Carvalho VC; de Oliveira PRD; Lima ALLM; Roberto Dos Reis P; Silva JDS
    Injury; 2021 Jul; 52 Suppl 3():S23-S28. PubMed ID: 34116851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro antibacterial effect of S53P4 bioactive glass and gentamicin impregnated polymethylmethacrylate beads.
    Gergely I; Zazgyva A; Man A; Zuh SG; Pop TS
    Acta Microbiol Immunol Hung; 2014 Jun; 61(2):145-60. PubMed ID: 24939683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections - A Multinational Study.
    Lindfors N; Geurts J; Drago L; Arts JJ; Juutilainen V; Hyvönen P; Suda AJ; Domenico A; Artiaco S; Alizadeh C; Brychcy A; Bialecki J; Romanò CL
    Adv Exp Med Biol; 2017; 971():81-92. PubMed ID: 28050878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.
    Malat TA; Glombitza M; Dahmen J; Hax PM; Steinhausen E
    Z Orthop Unfall; 2018 Apr; 156(2):152-159. PubMed ID: 29665602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S53P4 BIOACTIVE GLASS PUTTY IN THE LOCAL TREATMENT OF CAVITARY CHRONIC OSTEOMYELITIS.
    Reis GNBD; Cuba GT; Targa WHC; Miras PSC; Bongiovanni JC; Salles MJ; Reis FBD; Dell'aquila AM
    Acta Ortop Bras; 2023; 31(1):e258453. PubMed ID: 36844131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro.
    Coraça-Huber DC; Fille M; Hausdorfer J; Putzer D; Nogler M
    J Orthop Res; 2014 Jan; 32(1):175-7. PubMed ID: 24108602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review.
    van Gestel NA; Geurts J; Hulsen DJ; van Rietbergen B; Hofmann S; Arts JJ
    Biomed Res Int; 2015; 2015():684826. PubMed ID: 26504821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study.
    Romanò CL; Logoluso N; Meani E; Romanò D; De Vecchi E; Vassena C; Drago L
    Bone Joint J; 2014 Jun; 96-B(6):845-50. PubMed ID: 24891588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstruction of Vertebral Bone Defects using an Expandable Replacement Device and Bioactive Glass S53P4 in the Treatment of Vertebral Osteomyelitis: Three Patients and Three Pathogens.
    Kankare J; Lindfors NC
    Scand J Surg; 2016 Dec; 105(4):248-253. PubMed ID: 26929284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis.
    Lindfors NC; Hyvönen P; Nyyssönen M; Kirjavainen M; Kankare J; Gullichsen E; Salo J
    Bone; 2010 Aug; 47(2):212-8. PubMed ID: 20624692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study.
    Drago L; Romanò D; De Vecchi E; Vassena C; Logoluso N; Mattina R; Romanò CL
    BMC Infect Dis; 2013 Dec; 13():584. PubMed ID: 24325278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of Bioactive glass S53P4 in bone infections: a systematic review.
    Bigoni M; Turati M; Zanchi N; Lombardo AS; Graci J; Omeljaniuk RJ; Zatti G; Gaddi D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(2 Suppl):240-251. PubMed ID: 30977891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience.
    Steinhausen E; Lefering R; Glombitza M; Brinkmann N; Vogel C; Mester B; Dudda M
    J Bone Jt Infect; 2021; 6(4):73-83. PubMed ID: 34084694
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
    Vos J; de Vey Mestdagh P; Colnot D; Borggreven P; Orelio C; Quak J
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Growth Reduction of Five Clinical Pathogens by Injectable S53P4 Bioactive Glass Material Formulations.
    Thijssen EGJ; van Gestel NAP; Bevers R; Hofmann S; Geurts J; van Loo IHM; Arts JJ
    Front Bioeng Biotechnol; 2020; 8():634. PubMed ID: 32676498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis.
    McAndrew J; Efrimescu C; Sheehan E; Niall D
    Ir J Med Sci; 2013 Sep; 182(3):509-11. PubMed ID: 23292733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Real-World Administration of Concomitant
    Thronicke A; Reinhold T; von Trott P; Matthes H; Schad F
    Evid Based Complement Alternat Med; 2020; 2020():3543568. PubMed ID: 32256640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.